Allergan Stock Buy Or Sell -

: AbbVie is a known "Dividend King," having consistently increased its dividend for over 50 consecutive years.

Because Allergan has been integrated into AbbVie, you can no longer buy or sell "AGN" shares directly. Instead, investors seeking exposure to Allergan's former portfolio—including and Juvederm —must now trade AbbVie stock. Investment Profile for AbbVie (ABBV) allergan stock buy or sell

: Analysts are currently focused on AbbVie's ability to offset the loss of exclusivity for its flagship drug, Humira, through newer immunology drugs like Skyrizi and Rinvoq . : AbbVie is a known "Dividend King," having

: For the full year 2026, management has guided for net revenues of approximately $67 billion, representing 9.5% growth. Historical Acquisition Terms representing 9.5% growth. Historical Acquisition Terms